Psicofarmacología terapéutica y cosmética. Riesgos y límites
Otros títulos : 
Therapeutic and Cosmetic Psychopharmacology. Risks and Limits
Palabras clave : 
Psicofarmacología
Psychopharmacology
Medicina no terapéutica
Neuroética
Medical enhancement
Neuroethics
Fecha de publicación : 
2009
Editorial : 
Asociación Española de Bioética y Ética Médica
ISSN : 
1132-1289
Cita: 
Echarte Alonso LE. Therapeutic and cosmetic psychopharmacology. Risks and limits. Cuad Bioet 2009 May-Aug;20(69):211-230.
Resumen
In this paper, I analyze risks and limits of the current psychopharmacology and how both are promoting a new social interpretation of health concept. Besides, I show how such interpretation can be detected in four issues related to safety, equality, psychiatrization of human condition, and autonomy. In the conclusions, I defend, first, the obligation of physician to inform patients about the important long-term uncertainties around psychopharmacology. Second, I justify the necessity of promote more prolonged monitoring of patients treated with such kind of drugs. Third, I insist in the relevance of increasing research about drugs’ adverse effects extended over a long time. And forth, I bring up the utility of health concept to avoid the subjective stigmatization of cognitive or affective traits, to prevent potential problems of inequality and coercion, and to keep from mental disorders caused by attempts of getting psychical states supposedly optimized.

Ficheros en este ítem:
Vista previa
Fichero
Psicofarmacología terapéutica_Luis Echarte.pdf
Descripción
Tamaño
195 kB
Formato
Adobe PDF


Estadísticas e impacto
0 citas en
0 citas en

Los ítems de Dadun están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.